Ninety percent of professionals are adhering to the Digital Operational Resilience Act and the Network and Information Security Directive 2, ensuring compliance with regulations related to digital operational resilience and network security.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
